Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Chubb
Cipla
UBS
Healthtrust
Teva
Dow
QuintilesIMS
McKinsey
Chinese Patent Office

Generated: February 17, 2018

DrugPatentWatch Database Preview

DORAL Drug Profile

« Back to Dashboard

When do Doral patents expire, and when can generic versions of Doral launch?

Doral is a drug marketed by Cutis Health Llc and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in DORAL is quazepam. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the quazepam profile page.
Summary for DORAL
Drug patent expirations by year for DORAL
Pharmacology for DORAL
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine

US Patents and Regulatory Information for DORAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-003 Feb 26, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for DORAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 ➤ Sign Up ➤ Sign Up
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-003 Feb 26, 1987 ➤ Sign Up ➤ Sign Up
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 ➤ Sign Up ➤ Sign Up
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-003 Feb 26, 1987 ➤ Sign Up ➤ Sign Up
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 ➤ Sign Up ➤ Sign Up
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
QuintilesIMS
Chubb
Teva
Cantor Fitzgerald
Medtronic
Farmers Insurance
McKesson
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot